tiprankstipranks
Trending News
More News >
Heron Therapeutics (HRTX)
NASDAQ:HRTX
US Market

Heron Therapeutics (HRTX) Income Statement

Compare
1,625 Followers

Heron Therapeutics Income Statement

Last quarter (Q3 2025), Heron Therapeutics's total revenue was $38.21M, an increase of 16.47% from the same quarter last year. In Q3, Heron Therapeutics's net income was $-17.50M. See Heron Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 144.28M$ 127.04M$ 107.67M$ 86.35M$ 88.64M
Gross Profit
$ 105.64M$ 61.94M$ 52.80M$ 40.33M$ 52.45M
Operating Expenses
$ 117.17M$ 172.55M$ 227.46M$ 258.15M$ 280.61M
Depreciation and Amortization
$ 2.49M$ 2.90M$ 2.89M$ 3.02M$ 2.85M
EBITDA
$ -5.06M$ -103.79M$ -176.66M$ -215.25M$ -222.53M
Operating Income
$ -11.53M$ -110.61M$ -174.66M$ -217.83M$ -228.16M
Other Income/Expenses
$ -2.05M$ 56.00K$ -7.37M$ -2.85M$ 885.00K
Pretax Income
$ -13.58M$ -110.56M$ -182.02M$ -220.68M$ -227.28M
Net Income
$ -13.58M$ -110.56M$ -182.02M$ -220.68M$ -227.28M
Per Share Metrics
Basic EPS
$ -0.09$ -0.80$ -1.67$ -2.24$ -2.50
Diluted EPS
$ -0.09$ -0.80$ -1.67$ -2.24$ -2.50
Weighted Average Shares Outstanding
152.45M 138.13M 109.00M 98.47M 90.77M
Weighted Average Shares Outstanding (Diluted)
152.45M 138.13M 109.00M 98.47M 90.77M
Currency in USD

Heron Therapeutics Earnings and Revenue History